New Jersey Medical School (NJMS) has been selected by Moderna as one of over 90 sites across the United States to recruit adults to volunteer for the COVID-19 vaccine trial (known as the COVE Study) that will test the safety and effectiveness of the vaccine in approximately 30,000 participants nationwide. The Moderna trial is being conducted at New Jersey Medical School and University Hospital and at other institutions throughout New Jersey in collaboration with the National Institutes of Health. Rutgers is also likely to participate in additional vaccine trials over the next several months. To read the full story.
Recent Posts
- Rutgers-Newark Searches for New Ways to Enroll Men in Alzheimer’s Studies.
- Clinical Trials Day 2026 is May 20th – Submit an Abstract by February 13th
- Clinical trial in N.J. gives patients with incurable cancer a new chance at life.
- Entrepreneurship Lessons Coming to Introductory Engineering Courses.
- Scientists Develop Plastics That Can Break Down, Tackling Pollution.
Categories
- Community (2,431)
- Covid (996)
- CTO Events (6)
- News (3,078)
- Pilots (21)